Abstract
Marfan syndrome is an extracellular matrix disorder with cardinal manifestations in the eye, skeleton and cardiovascular systems associated with defects in the gene encoding fibrillin (FBN1) at 15q21.1 (ref. 1). A second type of the disorder (Marfan syndrome type 2; OMIM 154705) is associated with a second locus, MFS2, at 3p25–p24.2 in a large French family (family MS1)2. Identification of a 3p24.1 chromosomal breakpoint disrupting the gene encoding TGF-β receptor 2 (TGFBR2) in a Japanese individual with Marfan syndrome led us to consider TGFBR2 as the gene underlying association with Marfan syndrome at the MSF2 locus. The mutation 1524G→A in TGFBR2 (causing the synonymous amino acid substitution Q508Q) resulted in abnormal splicing and segregated with MFS2 in family MS1. We identified three other missense mutations in four unrelated probands, which led to loss of function of TGF-β signaling activity on extracellular matrix formation. These results show that heterozygous mutations in TGFBR2, a putative tumor-suppressor gene implicated in several malignancies, are also associated with inherited connective-tissue disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Collod-Béroud, G. & Boileau, C. Marfan syndrome in the third Millennium. Eur. J. Hum. Genet. 10, 673–681 (2002).
Collod, G. et al. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat. Genet. 8, 264–268 (1994).
Boileau, C. et al. Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am. J. Hum. Genet. 53, 46–54 (1993).
Hasham, S. et al. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107, 3184–3190 (2003).
Grady, W. et al. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res. 59, 320–324 (1999).
Grady, W. & Markowitz, S. Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet. 3, 101–128 (2002).
Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338 (1995).
Lucke, C. et al. Inhibiting mutations in the transforming growth factor β type 2 receptor in recurrent human breast cancer. Cancer Res. 61, 482–485 (2001).
Parsons, R. et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55, 5548–5550 (1995).
Tanaka, S., Mori, M., Mafune, K., Ohno, S. & Sugimachi, K. A dominant negative mutation of transforming growth factor-β receptor type II gene in microsatellite stable oesophageal carcinoma. Br. J. Cancer 82, 1557–1560 (2000).
Lu, S. et al. HNPCC associated with germline mutation in the TGF-β type II receptor gene. Nat. Genet. 19, 17–18 (1998).
Lu, S.-L., Kawabata, M., Imamura, T., Miyazono, K. & Yuasa, Y. Two divergent signaling pathways for TGF-β separated by a mutation of its type II receptor gene. Biochem. Biophys. Res. Commun. 259, 385–390 (1999).
Neptune, E. et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407–411 (2003).
Kinoshita, A. et al. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat. Genet. 26, 19–20 (2000).
Kissin, E.Y., Lemaire, R., Korn, J.H., & Lafyatis, R. Transforming growth factor β induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum. 46, 3000–3009 (2002).
Kaartinen, V. & Warburton, D. Fibrillin controls TGF-β activation. Nat. Genet. 33, 331–332 (2003).
Annes, J., Munger, J.S. & Rifkin, D.B. Making sense of latent TGFβ activation. J. Cell Sci. 116, 217–224 (2003).
Collod-Beroud, G. et al. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Hum. Mut. 22, 199–208 (2003).
De Paepe, A., Devereux, R.B., Dietz, H.C., Hennekam, R.C.M. & Pyeritz, R.E. Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Genet. 62, 417–426 (1996).
Matsukawa, R. et al. Eight novel mutations of the FBN1 gene found in Japanese patients with Marfan syndrome. Hum. Mut. 17, 71–72 (2001).
Roman, M.J., Devereux, R.B., Kramer-Fox, R. & O'Loughlin, J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am. J. Cardiol. 64, 507–512 (1989).
Cartegni, L., Chew, S.L. & Krainer, A. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285–298 (2002).
Acknowledgements
We thank the affected individuals and their families for their participation; Y. Noguchi, K. Miyazaki and N. Yanai for technical assistance; T. Imamura and K. Miyazono for cell lines Mv1Lu and DR-26 and reporter constructs p3TP-Lux and p15P751-Luc (with permission from J. Massague); and S. Tuffery-Giraud and C. Béroud for technical and scientific discussions. This study was supported in part by CREST, Japan Science and Technology Agency, and by Université René Descartes-Paris V, Ministère de l'Education Nationale, de l'Enseignement Supérieur, de la Recherche et de l'Insertion Professionnelle, Fondation de France, and Faculté de Médecine Necker.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Clinical data for members of the MSI family. (PDF 5 kb)
Rights and permissions
About this article
Cite this article
Mizuguchi, T., Collod-Beroud, G., Akiyama, T. et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36, 855–860 (2004). https://doi.org/10.1038/ng1392
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1392